Is the price fair?
What BLFS's price assumes
BioLife Solutions, Inc. trades at 30.2× earnings against 40.2× for the median Medical Instruments & Supplies name, cheaper than its own group.
30.2
Trailing P/E · Medical Instruments & Supplies median 40.2 · cheaper than the typical name in its group
- Price / sales
- 9.24
Price / sales · as of 2026-Q1
- Free cash flow yield
- 0.64%
Free cash flow yield · Medical Instruments & Supplies median 3.7%
- Growth the price implies
- +34%
Growth the price implies · What free cash flow would have to do every year for a decade to justify today's price, discounted at 9.0%.
Details›
- Price / book2026-Q1
- 2.52
- EV / EBIToperating margin 2.9%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 9.04
- Healthcare median P/E362 names
- 29.9
- Medical Instruments & Supplies median P/E29 names
- 40.2
- Free cash flow, trailing twelve months
- $8.6M
- Market capitalisation
- $1.34B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #4 of 19 by Smart Score